TUCSON
520.748.4400
About Us
Professional Staff
Board of Directors
Careers
Contact Us
Frederick Gardner
Cottrell Foundation
Successes
Ventures
Biotechnology
Medical Devices
Other
Historic Investments
Technologies
The CH2 Domain Scaffold – ABDURINS™
Deimmunized Sarcin Ribotoxin
Endotoxin-free ClearColi™ Expression System
Fibronectin Artificial Antibody Scaffold
Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF)
Pichia Classic Expression Platform
Pichia GlyoSwitch™ Protein Expression System
Shingles Vaccine Antigen
Ultrasound Tissue Harmonic Imaging
VIMPAT® (lacosamide) for Treatment of Epileptic Seizures
Innovate With Us
News & Events
Home
»
News & Events
»
2000
U.S. Patent for Bone- and Cartilage-Regeneration Technology Issues to RCT Technologies
12.19.2000
AlamX LLC Technology to Fight Antibiotic-Resistant Bacteria Gets U.S. Patent
12.19.2000
RCT Issues Exclusive License to DePuy AcroMed for Halo Fixation Pin
10.19.2000
AlamX LLC Targeting Bacterial Resistance to Beta-Lactam Antibiotics
8.14.2000
RCT Patents Oral Immunoglobulin Treatment
8.9.2000
Mitsubishi Corporation, MER and RCT Form Company to Commercialize Fullerenes
7.31.2000
New RCT Licensing Program Offers Popular Gene Expression Systems at Reasonable Rates
6.29.2000
Patent Allowance Gives STI Rights to Use Sertoli Cell Lines in Islet Transplantation, Cell-Based Gene Therapy
6.7.2000
New Canadian Venture Formed to Develop Therapy for Heart Disease and Stroke
4.14.2000
RCT Licensing Michigan Pioneer Gene Transfer Technology
3.8.2000
Post navigation
←
Older posts
News by Year
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
From concept
to market
Innovate with us ›